Lv1
40 积分 2025-04-22 加入
177Lu-Labeled Antibody–Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid Tumors
28天前
已完结
The role of hydrophilic linkers in next-generation antibody-drug conjugates
1个月前
已完结
AbClick Pro H: Scavenger-Free, Traceless Lys248 Conjugation Via O -Acyl Hydroxamate Chemistry for Homogeneous Antibody–Drug Conjugates (ADCs)
1个月前
已完结
AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Selective Antibody–Drug Conjugate Synthesis
1个月前
已完结
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
3个月前
已完结
Allogeneic CAR-T cell therapy in autoimmune diseases
4个月前
已完结
The landscape of cell and gene therapy today
4个月前
已完结
Current trends in exosomes as therapeutic drug delivery systems
4个月前
已完结
Cancer cell therapies: global clinical trial trends and emerging directions
4个月前
已完结
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6
5个月前
已完结
皖公网安备34019202002308
